- Home
- QUBT vs HCM Comparison
QUBT vs HCM Comparison
Compare QUBT & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUBT
- HCM
- Stock Information
- Founded
- QUBT 2001
- HCM 2000
- Country
- QUBT United States
- HCM Hong Kong
- Employees
- QUBT N/A
- HCM N/A
- Industry
- QUBT Computer Manufacturing
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- QUBT Technology
- HCM Health Care
- Exchange
- QUBT Nasdaq
- HCM Nasdaq
- Market Cap
- QUBT 2.7B
- HCM 2.5B
- IPO Year
- QUBT N/A
- HCM N/A
- Fundamental
- Price
- QUBT $14.80
- HCM $17.27
- Analyst Decision
- QUBT Buy
- HCM Buy
- Analyst Count
- QUBT 2
- HCM 2
- Target Price
- QUBT $18.50
- HCM $23.50
- AVG Volume (30 Days)
- QUBT 17.3M
- HCM 41.5K
- Earning Date
- QUBT 05-15-2025
- HCM 08-07-2025
- Dividend Yield
- QUBT N/A
- HCM N/A
- EPS Growth
- QUBT N/A
- HCM N/A
- EPS
- QUBT N/A
- HCM 0.04
- Revenue
- QUBT $385,000.00
- HCM $630,201,000.00
- Revenue This Year
- QUBT $64.08
- HCM $15.00
- Revenue Next Year
- QUBT $383.33
- HCM $19.91
- P/E Ratio
- QUBT N/A
- HCM $79.28
- Revenue Growth
- QUBT 45.83
- HCM N/A
- 52 Week Low
- QUBT $0.53
- HCM $11.51
- 52 Week High
- QUBT $27.15
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- QUBT 39.64
- HCM 52.60
- Support Level
- QUBT $14.63
- HCM $17.36
- Resistance Level
- QUBT $15.79
- HCM $19.50
- Average True Range (ATR)
- QUBT 1.20
- HCM 0.42
- MACD
- QUBT -0.56
- HCM -0.02
- Stochastic Oscillator
- QUBT 13.50
- HCM 30.62
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.